Skip to main content

Table 2 Spearman coefficients for the correlation between ASES subscales and clinical and psychosocial variables at all available timepoints

From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

  ASES pain ASES other symptoms ASES total
DAS28-CRP −0.35 −0.33 −0.37
HAQ 0.48 0.55 0.55
Pain (VAS) 0.46 0.46 0.50
Fatigue (VAS) 0.45 0.51 0.51
PGA (VAS) 0.46 0.47 0.51
SF-36 PCS 0.58 0.61 0.64
SF-36 MCS 0.33 0.52 0.44
IPQ-R illness coherence 0.37 0.50 0.46
IPQ-R treatment control 0.40 0.46 0.46
IPQ-R personal control 0.29 0.27 0.30
IPQ-R consequences 0.58 0.64 0.65
IPQ-R emotional representations 0.46 0.59 0.56
RAQoL 0.57 0.68 0.67
PhGA (VAS) −0.32 −0.34 −0.36
TJC28 −0.32 −0.31 −0.34
SJC28 −0.19 −0.17 −0.20
CRP −0.07 −0.06 −0.07
ESR −0.07 −0.07 −0.08
  1. ASES Arthritis Self-Efficacy Scale, DAS28 Disease Activity Score in 28 joints, HAQ Health Assessment Questionnaire, VAS visual analogue scale, PGA patient’s global assessment of disease activity, SF-36 Short-Form 36, PCS physical component score, MCS mental component score, IPQ-R Revised Illness Perception Questionnaire, PhGA physician’s global assessment of disease activity, TJC28 tender joint count in 28 joints, SJC28 swollen joint count in 28 joints, CRP C-reactive protein, ESR erythrocyte sedimentation rate